Canon Medical Partners with Rajiv Gandhi Institute for Cancer Diagnostics
New Delhi, Wednesday, 3 September 2025.
Canon Medical Systems India has teamed up with the Rajiv Gandhi Cancer Institute to utilize cutting-edge CT imaging technology, aiming to revolutionize cancer diagnostics and patient care in India.
Enhancing Diagnostic Capabilities with Advanced Technology
The collaboration between Canon Medical Systems India and Rajiv Gandhi Cancer Institute represents a strategic move to integrate advanced imaging technologies into clinical practice. At the heart of this partnership is Canon’s new flagship Aquilion ONE / INSIGHT Edition, a 640-slice CT system designed to offer superior imaging capabilities. This system combines wide-area coverage with deep learning-based artificial intelligence (AI), enabling more precise and detailed imaging for cancer diagnostics [1].
Revolutionizing Cancer Care with AI
Canon’s Aquilion ONE / INSIGHT Edition is equipped with groundbreaking features such as the Precise IQ Engine (PIQE) and the Advanced intelligent Clear-IQ Engine (AiCE). These features employ deep learning AI to enhance image clarity, allowing for a better delineation of small anatomical structures crucial for accurate cancer diagnosis. The SilverBeam Filter technology further optimizes the system by reducing radiation dose, ensuring patient safety during scans [1]. According to a study conducted using similar technology, the use of an Ag-filter in CT scanners significantly reduces absorbed doses, aligning them with levels found in standard chest radiography [6].
Impact on Healthcare and Patient Outcomes
The integration of AI and advanced imaging technologies is expected to significantly enhance diagnostic capabilities, leading to improved patient outcomes in cancer care. This partnership is seen as a pivotal step in transforming cancer diagnostics in India, where timely and accurate diagnosis is crucial for effective treatment. According to market forecasts, the global ultrasound AI market is projected to grow at a CAGR of 24.0% from 2025 to 2030, indicating a rising trend in the adoption of AI technologies in healthcare [7].
Future Prospects and Continued Innovation
This collaboration aligns with Canon Medical’s ‘Made for Life’ philosophy, which emphasizes providing innovative solutions to meet healthcare challenges. The partnership with Rajiv Gandhi Cancer Institute is expected to set a benchmark for similar collaborations in the future, fostering an environment of innovation and excellence in cancer diagnostics. As the healthcare industry continues to evolve with technological advancements, collaborations like this will play a crucial role in shaping the future of medical diagnostics [1][8].